How Food Affects Your Heart: The Science

How Food Affects Your Heart: The Science

Medical Disclaimer

This content is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Information is based on current medical literature and clinical guidelines but may not apply to your specific situation. Individual responses vary based on personal medical history and concurrent conditions. Always consult qualified healthcare providers for medical decisions. Never delay seeking medical care based on content you’ve read. If experiencing a medical emergency, seek immediate medical attention.

These articles provide education to enhance your healthcare partnership. All treatment decisions should involve your healthcare team. Use this knowledge to have informed discussions, not replace medical care.

In Brief

Food does not act on your heart the way a key turns a lock — one input, one effect. It acts on the artery wall, through a handful of biological systems that are running every hour of every day, whether or not you can feel them. The same meal can nudge inflammation, the lining of your blood vessels, your cholesterol particles, your blood sugar, and the bacteria in your gut, all at once. That is the entire reason a way of eating can rival a medication for some outcomes: a drug usually targets one of these systems, while a dietary pattern touches several together. This article explains those systems — five core pathways plus two more — so that the practical advice in the rest of the series rests on an understanding of why, not just a list of foods to eat. None of it requires perfection, and for some inherited conditions food is not enough on its own; both of those honest limits are part of the picture.

Food Is Something the Artery Wall Is Exposed To

It is tempting to treat “heart-healthy eating” as a scorecard — good foods earn points, bad foods lose them. That picture hides where the action actually happens: the wall of the artery.

Atherosclerosis — the disease behind most heart attacks and strokes — is a slow process in which the inner lining of an artery is injured, cholesterol-carrying particles lodge in the wall, the immune system responds, and a plaque builds over years. Food matters because its breakdown products enter the bloodstream within minutes of a meal and reach that wall directly: the fats, the sugars, the plant compounds, and the byproducts your gut bacteria make from what you ate. Some of those signals calm the wall; some inflame it. So eating is less a test you pass or fail than an exposure your cardiovascular system receives several times a day for a lifetime — and one of the few cardiovascular risks you can actually change.

The stakes are real: cardiovascular disease is the leading cause of death in the United States, about one in five deaths,[1] and diet is among the largest modifiable contributors to that burden — by some estimates the single largest.[2,3] The rest of this article explains how the exposure works — the five core pathways through which food reaches the artery wall, two further mechanisms, and where the honest limits of dietary change lie. Later articles build the practical patterns (Article 2), the macronutrients (Article 3), and everything after.

The Five Pathways, at a Glance

Nutrition reaches the cardiovascular system through five interconnected pathways, worth seeing together before we take them one at a time — because their power comes from acting simultaneously, a point we return to at the end.

Pathway 1: Inflammation

Inflammation is the immune system’s response to injury — more blood flow, immune cells called in, chemical alarm signals released. In a cut or an infection that is exactly what you want, and it resolves once the threat is gone. The problem in cardiovascular disease is inflammation that never switches off. A steady drip of inflammatory triggers — from excess body fat, smoking, poor diet, and other sources — keeps the response simmering inside the artery wall. There, immune cells called monocytes burrow in, swallow oxidized cholesterol, and turn into “foam cells,” the bloated, fat-laden cells that form the core of an early plaque. The same inflammatory signaling thins the fibrous cap over a plaque, which is what makes a plaque prone to rupture — the event that triggers most heart attacks.[9]

Food influences this in three main ways. Omega-3 fatty acids from fatty fish (salmon, mackerel, sardines) do something more interesting than simply “reducing” inflammation: the body converts EPA and DHA into compounds called resolvins and protectins that actively resolve it — signaling the cleanup crews to finish the job and stand down.[10] Polyphenols — plant compounds in berries, olive oil, tea, and cocoa — dial down the cell’s main pro-inflammatory switch (the NF-κB pathway) while turning up its antioxidant defenses (the Nrf2 pathway).[11] And fermentable fiber feeds gut bacteria that produce short-chain fatty acids, particularly butyrate, which travel through the blood and quiet inflammatory signaling body-wide.[12]

People who follow a Mediterranean-style pattern most closely tend to have lower levels of inflammatory markers in their blood — an association seen across observational studies, consistent with these mechanisms even though such studies cannot prove cause on their own.[13]

Pathway 2: Oxidative Stress

Every cell produces reactive molecules called free radicals as a normal byproduct of making energy. In moderation the body neutralizes them. Oxidative stress is what happens when they outpace those defenses — and free radicals damage whatever they touch, with cholesterol particles a favorite target. When a free radical attacks an LDL particle, it creates oxidized LDL, a form the immune system treats as foreign. Immune cells engulf it, cannot digest it, and become the same foam cells that drive plaque. This is the direct link between Pathways 1 and 2: oxidation creates the modified cholesterol that inflammation then reacts to. The two feed each other.[27]

The dietary lever here comes with an important caveat that the supplement industry got wrong for years. Antioxidants from whole foods — vitamins C and E, polyphenols, and carotenoids working alongside hundreds of other plant compounds — are associated with lower oxidative damage.[28] But isolated antioxidant supplements have repeatedly failed to reduce cardiovascular events in randomized trials, and high doses of some have signaled possible harm.[28] The lesson is not “antioxidants don’t matter” — it is that they appear to work as part of whole foods, not as pills. Beyond eating them, the other half of the strategy is reducing the sources of oxidative stress in the first place: excess body fat, high blood sugar, and smoking all increase the load your defenses must handle. Cooking method plays a smaller role too — very high-heat methods generate advanced glycation end products (AGEs), and Article 7 takes that up in detail.[36,37]

Pathway 3: Endothelial Function

The endothelium is the single layer of cells lining every blood vessel, and it is far more than a pipe lining — it is an active organ that decides moment to moment how open a vessel is, whether blood clots, and what gets into the wall. Its most important product is nitric oxide, a short-lived gas that relaxes the vessel (lowering pressure), keeps immune cells and platelets from sticking, and limits the muscle-cell overgrowth that narrows arteries. When the endothelium falters, nitric oxide falls, vessels stiffen, pressure climbs, and atherosclerosis speeds up. Endothelial dysfunction is one of the earliest measurable steps toward heart disease — present long before any symptom.[14]

Several foods support nitric oxide. Leafy green vegetables supply dietary nitrate, which the body converts — first by bacteria on the tongue, then in the tissues — into nitric oxide, measurably improving vessel function within hours of a meal.[15] L-arginine, an amino acid in nuts, seeds, and legumes, is the raw material the endothelium’s own enzyme uses to build nitric oxide — though in practice a typical diet already supplies enough, so eating more is less reliably useful than the leafy-green nitrate route.[16] Polyphenols from cocoa, berries, and tea both boost nitric oxide production and protect it from being destroyed by oxidative stress.[17] Minerals matter independently of nitric oxide: sodium raises blood volume and stiffens arteries in the roughly half of people with hypertension who are salt-sensitive, while potassium does the reverse — relaxing vessels and helping the kidneys clear sodium — and magnesium helps vessel muscle relax.[39,40] The blood-pressure benefit of the DASH diet comes largely from this mineral rebalancing: much more potassium from produce and legumes, with moderated sodium.

Pathway 4: Lipid Metabolism

This is the pathway most people associate with food and the heart, and the mechanics are worth getting right. Your liver is the command center: it makes cholesterol, packages it into LDL particles for delivery to the body, and clears excess cholesterol through HDL. Most of the cholesterol in your blood is made by your own liver rather than eaten directly — which is why dietary cholesterol turns out to matter less than the type of fat you eat.[18] When LDL particles are too numerous, they accumulate; the small, dense ones in particular slip through the endothelial lining into the wall, where they oxidize and set off the plaque-building cascade.

The dietary levers act at different points:

• Soluble (viscous) fiber — beta-glucan from oats, and psyllium — binds bile acids in the intestine and carries them out of the body. Since the liver makes bile acids from cholesterol, it must pull cholesterol from the blood to replace them. Five to ten grams a day lowers LDL by roughly 5% — for someone at an LDL of 150 mg/dL, a drop of about 7–8 points.[20]
• Plant sterols block cholesterol absorption in the gut by competing for the same uptake machinery. About 2 grams daily lowers LDL by roughly 10% — about 15 points off that same 150.[19] An honest caveat travels with this one: plant sterols reliably lower LDL, but whether that translates into fewer heart attacks has not been established in outcome trials, so they are best used within a whole dietary pattern (like the Portfolio diet) rather than as a stand-alone supplement, and avoided in the rare disorder sitosterolemia.[33,34]
• Replacing saturated fat with unsaturated fat changes how the liver handles cholesterol and shifts LDL toward the larger, less dangerous particle type.[21]
• Trans fats from partially hydrogenated oils are the singular exception in all of nutrition: they raise LDL and lower HDL at the same time — a combination no other fat produces — while also raising Lp(a) and inflaming the vessel lining.[38] This is why eliminating industrial trans fat is the one truly absolute dietary rule for the heart. Most countries have restricted them, but they can still appear in some fried and baked goods; “partially hydrogenated oil” on an ingredient list is the tell.

Put together as the Portfolio diet — plant sterols, viscous fiber, soy protein, and nuts — these levers lowered LDL by about 29% in four weeks in a randomized trial, a drop comparable in magnitude to a moderate-intensity statin.[8] The honest qualifier: that comparison is about the size of the cholesterol change, not proven event reduction — statins have decades of hard-outcome trials behind them, and the Portfolio pattern does not yet.

Where food reaches its limit. Some people carry genes that diet cannot overcome. In familial hypercholesterolemia, the receptors that clear LDL from the blood are defective, so even excellent eating produces only modest further lowering — medication is required, not because diet “failed” but because the cellular machinery it would work through is broken.[34] Lipoprotein(a), or Lp(a), is similarly set largely by genetics and barely moves with diet.[33] Naming this is not discouraging; it is the difference between honest guidance and false promises. For these conditions, food plus medication is the protective combination, and the food still earns its keep through the other four pathways.

Pathway 5: Insulin Sensitivity

Insulin is usually described as the blood-sugar hormone, but it is better understood as a growth-and-storage signal that touches the whole cardiovascular system. When cells stop responding to it well — most often because of excess fat around the organs — the pancreas compensates by pumping out more. Chronically high insulin tells the kidneys to hold onto sodium (raising blood pressure), prods artery muscle to thicken (narrowing the vessel), and drives the liver to make more triglycerides.[22] Meanwhile the high blood sugar that accompanies insulin resistance does its own damage: glucose chemically bonds to proteins in the artery wall (glycation), stiffening vessels and stoking inflammation.[23]

Food improves insulin sensitivity mainly through fiber, which slows the absorption of sugar so the post-meal rise is gentler, and whose fermentation products improve how cells respond to insulin at the molecular level;[24] and through healthy fats, where monounsaturated and omega-3 fats are built into cell membranes in a way that keeps insulin receptors responsive, while excess saturated fat does the opposite.[25] In randomized trials, Mediterranean and DASH patterns improved insulin sensitivity by roughly 15–25% over three to six months — and notably, partly independent of weight loss, meaning the food itself does work beyond simply helping people slim down.[26]

As with cholesterol, there is an honest limit: genetics shape the response. If well-executed dietary change has not meaningfully moved your risk factors after a couple of months, that is a signal to add medication, not to try harder in vain — and the diet keeps protecting you through the other pathways regardless.

Two More Mechanisms: The Gut and Clotting

Beyond the five core pathways, two further mechanisms deserve mention because they explain things the others do not.

The gut–heart axis. The trillions of bacteria in your gut are, in effect, a metabolic organ that responds to what you feed it. The clearest cardiovascular link runs through a compound called TMAO. When gut bacteria break down certain nutrients concentrated in red meat (and present in eggs and dairy), they produce a precursor the liver converts into TMAO, which has been associated with foam-cell formation, stickier platelets, and impaired vessel function.[32,35] People who regularly eat red meat cultivate the bacterial species that make TMAO efficiently; those who eat mostly plants largely lack them and make little TMAO even when given the precursor directly.[35] This is part of why plant-rich patterns appear protective beyond their effect on cholesterol — though it is worth noting that TMAO’s exact causal weight in human disease is still debated, an active area of research rather than a closed case. The flip side is the fiber story from Pathway 1: feeding beneficial bacteria fiber yields the short-chain fatty acids that lower inflammation and support insulin sensitivity. A plant-rich diet works both levers — feeding the helpful bacteria, starving the TMAO-makers.

Clotting. Most heart attacks happen not when an artery slowly closes but when a plaque ruptures and a clot forms on it in minutes. Diet nudges the clotting balance: omega-3s make platelets slightly less prone to clumping by changing their membrane chemistry, which is one proposed reason fish intake is linked to fewer sudden cardiac deaths;[30] and polyphenols from grapes, berries, and tea calm overactive platelets at dietary doses without raising bleeding risk.[31] (Vitamin K from leafy greens is needed to make clotting factors and is safe for most people, but anyone on warfarin should keep their intake steady and discuss it with their clinician — covered in Article 16.)

Why Acting on Many Pathways at Once Is the Whole Point

The pathways are not separate lanes — they feed one another. Inflammation worsens insulin resistance; insulin resistance damages the endothelium; a damaged endothelium makes less nitric oxide and tolerates more oxidation; oxidation drives more inflammation. Left unchecked, the loop tightens on itself.

A single medication usually enters this loop at one point — a statin lowers cholesterol, a blood-pressure drug relaxes vessels. That is genuinely valuable and, for many people, necessary. A whole dietary pattern enters at several points at once, nudging inflammation, the endothelium, the lipid profile, insulin, oxidation, and the gut together. It is not more powerful than medicine at any single one of those jobs; its strength is breadth. That breadth is the honest explanation for why dietary patterns can produce effects that, for certain outcomes, rival drugs — not because a food is potent, but because the pattern works on many contributors rather than one.

The most striking demonstration came from the Lifestyle Heart Trial, in which a small group of patients with established coronary disease followed an intensive program — a very-low-fat plant-based diet plus exercise, stress management, and smoking cessation — and showed measurable regression of coronary plaque at one year, with even more regression at five, while a usual-care group worsened. It remains a landmark: among the first randomized evidence that lifestyle change alone could reverse, not just slow, established disease.[4] The sample was small and the program intensive, so it is a proof of concept rather than a typical result — but the concept it proved is the one this whole pathway map predicts.

What the Evidence Actually Shows — and How Much

Mechanisms are reassuring, but the question that matters is whether eating this way changes outcomes, and by how much. Four landmark trials anchor the rest of this series, and they are worth seeing with honest numbers — both the relative reduction (which sounds large) and the absolute reduction (which tells you what it meant for real people).

• PREDIMED assigned about 7,400 people at high cardiovascular risk to a Mediterranean diet (with extra olive oil or nuts) or a lower-fat control diet. Over roughly five years, the Mediterranean groups had about 30% fewer major cardiovascular events — heart attack, stroke, or cardiovascular death.[5] In absolute terms that worked out to roughly 3 fewer such events per 1,000 people per year: meaningful across a population, modest for any one person in a single year, and larger the longer it is sustained. Both framings are true, and you need both to judge it honestly.
• The Lyon Diet Heart Study followed 605 people who had already had a heart attack. Those assigned a Mediterranean-style diet had 14 recurrences of cardiac death or nonfatal heart attack versus 44 in the control group over about four years — roughly a 70% relative reduction, a large effect in a high-risk group where the baseline event rate is high.[6]
• DASH was a feeding study in people with elevated blood pressure: it lowered systolic pressure by about 11 mmHgand diastolic by about 6 mmHg within weeks.[7] A drop of that size, based on blood-pressure epidemiology rather than DASH’s own event data, would be expected to translate into substantially lower stroke and coronary risk over time — but DASH measured the pressure, not the events, and that distinction is the honest one to keep.
• The Portfolio diet lowered LDL cholesterol by about 29% in four weeks — a magnitude comparable to a moderate-intensity statin, with the same caveat noted earlier that the comparison is about cholesterol change, not proven event reduction.[8]

A reasonable reading of all four together: dietary patterns produce real, measurable cardiovascular benefit; the effect is largest in those at highest risk and when sustained over years; and the place where the evidence is strongest (Mediterranean pattern, hard outcomes, primary and secondary prevention) is exactly where this series will spend the most time.

What This Means for You

If you are working to prevent heart disease, the pathway map is the case for not waiting. The exposure is happening now, the early changes (endothelial function, blood pressure) begin within weeks, and the largest benefit accrues to those who start before disease is advanced.

If you already have cardiovascular disease, food works alongside your medications, not instead of them — and the two are complementary, each entering the loop at different points. The Lyon and Lifestyle Heart results are most relevant to you, because the absolute benefit is largest when baseline risk is high.

If you have a genetic condition like familial hypercholesterolemia or elevated Lp(a), the honest message is that food alone will not reach safe targets, medication is not a personal failure, and the combination is what protects you.

And for everyone: none of this requires perfection. The pathways respond to your overall pattern of eating over time, not to any single meal — so no one meal can ruin your progress, and none can rescue it.

In practice, every pathway in this article points in the same direction, which is worth stating plainly even though Article 2 is where it gets specific: more vegetables, fruit, legumes, nuts, whole grains, fish, and olive oil; less ultra-processed food, refined starch and added sugar, and red and processed meat; and industrial trans fat eliminated outright. That single pattern is what activates inflammation resolution, antioxidant defenses, nitric oxide, healthy lipid handling, steady insulin, and a favorable gut — all at once. You do not need to act on the pathways one by one; eating this way does it for you.

The Bottom Line

Food reaches the heart through biology — five pathways at the artery wall, plus the gut and the clotting system, each running continuously and responding to what you eat. A whole pattern of eating can stand alongside medication for some outcomes not because any single food is potent, but because the pattern works on several of these systems at once, while most drugs work on one. That breadth is real and measurable, and the benefit is largest for people at high risk and those who sustain it for years. It is also bounded honestly: some inherited conditions need medication regardless of diet, and the protection comes from the overall pattern over years, not from any single meal.

What Comes Next

Article 2 turns these mechanisms into three concrete, tested eating patterns — Mediterranean, DASH, and Portfolio — with guidance on which fits which cardiovascular situation and how to put it into practice.

Key Terms

Atherosclerosis: The disease process in which the artery wall is injured, accumulates cholesterol and immune cells, and builds plaque over years; the basis of most heart attacks and strokes.

Endothelium: The single-cell lining of all blood vessels; an active regulator of vessel tone, clotting, and what enters the wall. Its dysfunction is an early step in heart disease.[14]

Nitric oxide (NO): A short-lived gas made by the endothelium that relaxes vessels, lowers blood pressure, and discourages clotting and immune-cell adhesion.[15]

Foam cell: An immune cell that has engulfed oxidized cholesterol and become trapped in the artery wall; the building block of early plaque.[9,27]

Oxidized LDL: An LDL cholesterol particle damaged by free radicals, which the immune system treats as foreign — a key trigger of plaque formation.[27]

Plant sterols: Plant compounds that block cholesterol absorption in the gut, lowering LDL by roughly 10% at about 2 g/day; outcome data remain limited.[19,33]

Soluble (viscous) fiber: Fiber from oats, psyllium, and similar foods that binds bile acids and lowers LDL by prompting the liver to draw cholesterol from the blood.[20]

Trans fat: Industrial fat from partially hydrogenated oil that uniquely raises LDL and lowers HDL together; the one fat to eliminate entirely.[38]

Insulin resistance: A state in which cells respond poorly to insulin, raising insulin and blood-sugar levels and damaging vessels through several routes; central to the link between metabolism and heart disease.[22,23]

TMAO (trimethylamine N-oxide): A compound produced when gut bacteria metabolize nutrients concentrated in red meat; associated with cardiovascular risk, though its precise causal role is still debated.[32,35]

Familial hypercholesterolemia: An inherited defect in LDL clearance that keeps cholesterol high despite excellent diet, requiring medication.[34]

Lipoprotein(a) / Lp(a): An LDL-like particle set largely by genetics and minimally responsive to diet; an independent cardiovascular risk factor.[33]

References

1. Martin SS, Aday AW, Almarzooq ZI, et al. 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Circulation. 2024;149(8):e347-e913.
2. GBD 2017 Diet Collaborators. Health effects of dietary risks in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019;393(10184):1958-1972.
3. Micha R, Peñalvo JL, Cudhea F, Imamura F, Rehm CD, Mozaffarian D. Association Between Dietary Factors and Mortality From Heart Disease, Stroke, and Type 2 Diabetes in the United States. JAMA. 2017;317(9):912-924.
4. Ornish D, Scherwitz LW, Billings JH, et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA. 1998;280(23):2001-2007.
5. Estruch R, Ros E, Salas-Salvadó J, et al. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts. N Engl J Med. 2018;378(25):e34.
6. de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation. 1999;99(6):779-785.
7. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997;336(16):1117-1124.
8. Jenkins DJ, Kendall CW, Marchie A, et al. Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. JAMA. 2003;290(4):502-510.
9. Libby P. Inflammation in atherosclerosis. Nature. 2002;420(6917):868-874.
10. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol. 2008;8(5):349-361.
11. Vita JA. Polyphenols and cardiovascular disease: effects on endothelial and platelet function. Am J Clin Nutr.2005;81(1 Suppl):292S-297S.
12. Slavin J. Fiber and prebiotics: mechanisms and health benefits. Nutrients. 2013;5(4):1417-1435.
13. Chrysohoou C, Panagiotakos DB, Pitsavos C, Das UN, Stefanadis C. Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: The ATTICA Study. J Am Coll Cardiol.2004;44(1):152-158.
14. Gimbrone MA Jr, García-Cardeña G. Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis. Circ Res. 2016;118(4):620-636.
15. Lundberg JO, Weitzberg E, Gladwin MT. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov. 2008;7(2):156-167.
16. Böger RH, Bode-Böger SM. The clinical pharmacology of L-arginine. Annu Rev Pharmacol Toxicol. 2001;41:79-99.
17. Leikert JF, Räthel TR, Wohlfart P, Cheynier V, Vollmar AM, Dirsch VM. Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation.2002;106(13):1614-1617.
18. Grundy SM. Absorption and metabolism of dietary cholesterol. Annu Rev Nutr. 1983;3:71-96.
19. Ostlund RE Jr. Phytosterols in human nutrition. Annu Rev Nutr. 2002;22:533-549.
20. Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr. 1999;69(1):30-42.
21. Kris-Etherton PM, Yu S. Individual fatty acid effects on plasma lipids and lipoproteins: human studies. Am J Clin Nutr. 1997;65(5 Suppl):1628S-1644S.
22. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595-1607.
23. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414(6865):813-820.
24. Weickert MO, Pfeiffer AFH. Impact of Dietary Fiber Consumption on Insulin Resistance and the Prevention of Type 2 Diabetes. J Nutr. 2018;148(1):7-12.
25. Imamura F, Micha R, Wu JH, et al. Effects of Saturated Fat, Polyunsaturated Fat, Monounsaturated Fat, and Carbohydrate on Glucose-Insulin Homeostasis: A Systematic Review and Meta-analysis of Randomised Controlled Feeding Trials. PLoS Med. 2016;13(7):e1002087.
26. Esposito K, Marfella R, Ciotola M, et al. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA. 2004;292(12):1440-1446.
27. Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev. 2004;84(4):1381-1478.
28. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev. 2012;3:CD007176.
29. Egert S, Rimbach G. Which sources of flavonoids: complex diets or dietary supplements? Adv Nutr. 2011;2(1):8-14.
30. von Schacky C. Omega-3 fatty acids and cardiovascular disease. Curr Opin Clin Nutr Metab Care. 2007;10(2):129-135.
31. Freedman JE, Parker C 3rd, Li L, et al. Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation. 2001;103(23):2792-2798.
32. Wang Z, Klipfell E, Bennett BJ, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472(7341):57-63.
33. Tsimikas S. A Test in Context: Lipoprotein(a): Diagnosis, Prognosis, Controversies, and Emerging Therapies. J Am Coll Cardiol. 2017;69(6):692-711.
34. Nordestgaard BG, Chapman MJ, Humphries SE, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease. Eur Heart J.2013;34(45):3478-3490.
35. Koeth RA, Wang Z, Levison BS, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19(5):576-585.
36. Uribarri J, Woodruff S, Goodman S, et al. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc. 2010;110(6):911-16.e12.
37. Vlassara H, Uribarri J. Advanced glycation end products (AGE) and diabetes: cause, effect, or both? Curr Diab Rep. 2014;14(1):453.
38. Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Trans fatty acids and cardiovascular disease. N Engl J Med. 2006;354(15):1601-1613.
39. Elijovich F, Weinberger MH, Anderson CA, et al. Salt Sensitivity of Blood Pressure: A Scientific Statement From the American Heart Association. Hypertension. 2016;68(3):e7-e46.
40. Aburto NJ, Hanson S, Gutierrez H, Hooper L, Elliott P, Cappuccio FP. Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ. 2013;346:f1378.

HeartBuddi • Your heart. Own it.